Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility

Use of budget savings from patent expiration of cancer drugs to improve affordability and accessibility

Abstract Background The introduction of generics after the loss of patent exclusivity plays a major role in budget savings by significantly decreasing drug prices. The aims of this study were to estimate the budget savings from off-patent cancer drugs in 2020–2024 and to inform decision makers on ho...

Full description

Bibliographic Details
Main Authors: Seung Mi Lee, Heui Jae Kim, David Suh, Kyung-In Joung, Eun Suk Kim, Hee Jung Back, Jun Young Kwon, Man-Jae Park, Dong Churl Suh
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Health Services Research
Subjects:
Patent expiration
Cancer drug
Price
Budget savings
Generics
Biosimilars
Online Access:https://doi.org/10.1186/s12913-021-06130-y

Internet

https://doi.org/10.1186/s12913-021-06130-y

Similar Items